Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Emerging Oncology Drugs in Pharma R&D Pipeline

Posted on March 2nd, 2017 by in Pharma R&D

Cancer. It’s the 2nd leading cause of death in this country (1), and a disease feared by patients and healthcare professionals alike. Today’s cancer treatments vary in nature, and also, efficacy and levels of side effect profiles. Continue reading “Emerging Oncology Drugs in Pharma R&D Pipeline” »

Start-Up Spotlight: StemCiTerra, LLC

Posted on February 17th, 2017 by in Pharma R&D

StemCiTerra, LLC is a small American start-up with a mission to make cancer treatments more effective. The company’s President & CSO, Lyubov Ostrovska, Ph.D., chats about their research. Continue reading “Start-Up Spotlight: StemCiTerra, LLC” »

Cancer Moonshot: Report Research Trends Released

Posted on January 18th, 2017 by in Pharma R&D

Last year we discussed the new Cancer Moonshot, a White House initiative being headed by out-going Vice-President Joe Biden. Continue reading “Cancer Moonshot: Report Research Trends Released” »

An Update from Myelo: Expanding Our Team and Evaluating Data

Posted on December 14th, 2016 by in Pharma R&D

The focus of our current non-clinical research at Myelo Therapeutics is to fully elucidate the mode of action for prevention of myelosuppression as well as Myelo001’s antiviral capabilities. But to achieve this goal, it’s important to have highly skilled and motivated personnel within your team. Continue reading “An Update from Myelo: Expanding Our Team and Evaluating Data” »

  1. 1
  2. 2